How Technological Advancements Are Fueling Market Growth in Cell Viability Assays
As the healthcare landscape evolves, the Cell Viability Assays Market is witnessing remarkable growth, driven by technological advancements and a surge in drug discovery applications. This market, valued at approximately USD 2.24 billion in 2022, is projected to reach about USD 5.48 billion by 2035, all while maintaining a compound annual growth rate (CAGR) of 8.50%. Such robust growth...
0 Comments 0 Shares 199 Views 0 Reviews